Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
Darendeliler
F
F
Istanbul Faculty of Medicine, Department of Pediatrics, Turkey.
Baş
F
F
D002648:Child; D005260:Female; D006042:Goiter / Q000188:drug therapy; D006801:Humans; D010902:Pituitary Gland / Q000503:physiopathology; D018382:Thyroid Hormone Resistance Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use
D014284:Triiodothyronine; C010642:3,3',5-triiodothyroacetic acid; D013972:Thyrotropin; D013974:Thyroxine